An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis

Nannan Li*, Dennis Cornelissen, Stuart Silverman, Daniel Pinto, Lei Si, Ingrid Kremer, Sandrine Bours, Robin de Bot, Annelies Boonen, Silvia Evers, Joop van den Bergh, Jean-Yves Reginster, Mickael Hiligsmann

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)181-209
Number of pages29
JournalPharmacoeconomics
Volume39
Issue number2
Early online date7 Oct 2020
DOIs
Publication statusPublished - Feb 2021

Keywords

  • POSTMENOPAUSAL OSTEOPOROSIS
  • ORAL BISPHOSPHONATES
  • ECONOMIC EVALUATIONS
  • VERTEBRAL FRACTURES
  • ZOLEDRONIC ACID
  • DENOSUMAB
  • WOMEN
  • ALENDRONATE
  • PREVENTION
  • DISCONTINUATION

Cite this